Suchergebnisse
Suchergebnisse:
April 1962 in Merchtem) ist eine belgische Allgemeinmedizinerin und Politikerin der Open Vlaamse Liberalen en Democraten (Open VLD). Sie war von Oktober 2014 bis 30. September 2020 Ministerin für Gesundheit und Soziales in der föderalen Regierung. De Block ist zudem seit 1999 Mitglied der föderalen Abgeordnetenkammer.
Open VLD (2007–present) VLD (1999–2007) Alma mater. Free University of Brussels, dutch. Maggie Celine Louise De Block ( [ˈmɛɡi sɛˈlin luˈiz də ˈblɔk], born 28 April 1962) is a Belgian politician of the Open VLD [1] who has been chairing her party's group in the Chamber of Representatives since 2020.
Maggie Celine Louise De Block ( Merchtem, 28 april 1962) is een Belgisch politica van de Open Vld. [2] Levensloop. Na haar middelbare studies Latijn-Wetenschappen in het Koninklijk Lyceum te Laken studeerde ze geneeskunde aan de Vrije Universiteit Brussel, alwaar ze afstudeerde als doctor in de genees-, heel- en verloskunde.
30. Sept. 2020 · Maggie De Block, who led Belgium through various emergencies since 2014, will no longer serve as health minister in the new government. She will be replaced by a coronavirus commissioner, while she remains a member of parliament.
24. Sept. 2020 · Maggie De Block is a Belgian politician and former health minister who has been a member of the Chamber of Representatives since 2020. She is also involved in various international initiatives on health issues and has been featured in several POLITICO articles on the coronavirus crisis and other topics.
Maggie Celine Louise De Block, health minister of Belgium, has been a prominent figure in the country's politics, especially in public health. Maggie De Block’s role as the health leader of Belgium has been crucial in putting into practice many laws and programmes designed to enhance healthcare and solve urgent health issues in the nation.
27. Juli 2015 · Belgian health minister Maggie De Block. July 27, 2015 6:02 pm CET. By Peter O’Donnell. Belgium and groups representing branded and generic pharmaceutical companies signed a complex four-year deal on Monday aimed at approving drugs faster and drilling prices down.
